Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease
In The News - Infectious Disease
SelectScience Interview | January 29, 2018
November 18, 2015
American Laboratory Read the article at www.americanlaboratory.com.
September 15, 2015
GenomeWeb Read the article at www.genomeweb.com.
March 9, 2015
Clinical Lab Products
March 5, 2015
GlobalNewswire Read the article at www.globalnewswire.com
February 20, 2015
GenomeWeb Read the article at www.genomeweb.com